Expect Dr Reddys stock to surge high in April

By IndianCEO Team

Posted on March 31, 2021

Dr Reddys which is currently trading today at 4500 is expected to have huge gains in the coming month.

DR Reddys has approached regulatory authority to get approval for a single-dose Covid vaccine Sputnik and the same is expected to be completed in a couple of weeks.

Dr Reddys in partnership with Russia is planning to manufacture a few million doses of sputnik of both domestic and international use. Currently, India has already approved two covid vaccines Covaxin and Covishield.

Sputnik has a higher advantage than the other two vaccines because it required only a single dose instead of two doses.

Dr Reddys Stock is expected to have good gains and reach 5000 which is a 3 month high for it.

Expect Dr Reddys stock to surge high in April